Hypopharyngeal Cancer
📧 Sign up to get email alerts when something new happens for Hypopharyngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating lymphocyte-sparing radio-immunotherapy for head and neck cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]
This Phase 2 clinical trial is evaluating BMX-001 as a radioprotector added to standard chemoradiation therapy for head and neck cancers and…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, inclu…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin [Phase 3]
Phase 3 clinical trial update on radiation plus cetuximab versus radiation plus non-cisplatin chemotherapy for head and neck cancer patients…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating sacituzumab govitecan in combination with cetuximab for head and neck squamous cell cancers is currently r…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors [NA]
The ENHANCE study is an active, not-recruiting trial assessing exercise and nutrition interventions for head and neck cancer survivors, incl…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Neoadjuvant Treatment of Locally Advanced Hypopharyngeal Cancer With Adebrelimab Combined With TP Chemotherapy Regimen [Phase 2]
Phase 2 neoadjuvant trial evaluating Adebrelimab in combination with a TP chemotherapy regimen for locally advanced hypopharyngeal cancer.
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer
This clinical trial update describes a study investigating whether voice analysis can help detect recurrence in patients with laryngeal or h…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients [Phase 1]
Phase 1 clinical trial evaluating thermoradiotherapy for locally advanced head and neck cancers; recruitment is ongoing.
-
CLINICAL_TRIALS research · 2025-05-22Clinical Trial Update: Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment [NA]
An update on a completed clinical trial evaluating exercise training and behavioral modification to boost physical activity in patients unde…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: A Prospective, Multicenter, Multicohort Phase II Study: Evaluating the Efficacy and Safety of Preoperative Neoadjuvant Treatment With a PD-1 Inhibitor in Combination With Chemotherapy in Locally Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma [Phase 2]
Phase II multicenter study evaluating neoadjuvant therapy with a PD-1 inhibitor in combination with chemotherapy for locally advanced laryng…
-
CLINICAL_TRIALS research · 2025-03-25Clinical Trial Update: Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
A clinical trial is recruiting elderly patients with head and neck squamous cell carcinoma undergoing radiotherapy. The study covers cancers…
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer [Phase 1]
Phase 1 study evaluating adding BAY 1895344 with radiation therapy to pembrolizumab for recurrent head and neck squamous cell carcinomas, ai…
-
CLINICAL_TRIALS research · 2024-08-14Clinical Trial Update: Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer [Phase 2]
Phase 2 trial evaluating tislelizumab with induction chemotherapy for larynx preservation in resectable advanced laryngeal/hypopharyngeal ca…
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma [Phase 2]
A Phase 2 neoadjuvant trial evaluating a PD-1 inhibitor with cetuximab and platinum for resectable locally advanced hypopharyngeal cancer is…
-
CLINICAL_TRIALS research · 2017-12-12Clinical Trial Update: Neck Dissection vs Radiotherapy for Cervical Metastases in Advanced Hypopharyngeal Cancer [NA]
This clinical trial update outlines a study comparing neck dissection surgery to radiotherapy for cervical metastases in advanced hypopharyn…
-
CLINICAL_TRIALS research · 2016-09-08Clinical Trial Update: Value of Narrow Band Imaging (NBI) Endoscopy in the Early Diagnosis of Laryngeal Cancer and Precancerous Lesions [NA]
A completed clinical trial from University Hospital Ostrava evaluated the value of narrow-band imaging endoscopy for early detection of lary…
-
CLINICAL_TRIALS research · 2014-06-06Clinical Trial Update: Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer [Phase 1]
This Phase 1 clinical trial update examines a combination regimen of Erlotinib, Docetaxel, and radiation therapy for locally advanced head a…
-
CLINICAL_TRIALS research · 2014-02-06Clinical Trial Update: Radiation Therapy With or Without Cetuximab in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx, Hypopharynx, or Larynx [Phase 3]
This is a Phase 3 clinical trial comparing radiation therapy with or without cetuximab for stage III/IV cancers of the oropharynx, hypophary…
-
CLINICAL_TRIALS research · 2012-03-20Clinical Trial Update: Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer [Phase 2]
Clinical trial update for a Phase 2 study evaluating nimotuzumab in combination with neoadjuvant and concurrent chemoradiotherapy for oropha…
-
CLINICAL_TRIALS research · 2011-03-23Clinical Trial Update: Parotid-Sparing Intensity-Modulated Radiation Therapy Compared With Conventional Radiation Therapy in Treating Patients With Oropharyngeal or Hypopharyngeal Cancer Who Are at High Risk of Radiation-Induced Xerostomia [Phase 3]
Phase 3 clinical trial comparing parotid-sparing intensity-modulated radiation therapy with conventional radiation therapy for oropharyngeal…